Brister, Danica
Khan, Sana
Abraham, Ted
Laventure, Samuel
Sahakian, Sevag
Juliá, Berta
Satia, Imran
Funding for this research was provided by:
Merck Canada
Article History
Received: 19 April 2024
Accepted: 30 May 2024
First Online: 12 June 2024
Declarations
:
: DB is supported by McMaster University and reports grants from the University of Calgary. SK has no conflicts of interest.SL, TA, and SS are employees of Merck Canada Inc., Kirkland, QC, Canada, the study sponsor. BJ is an employee of MSD Spain. IS is currently supported by the E.J. Moran Campbell Early Career Award, McMaster University and reports grants from ERS Respire 3 Marie Curie fellowship, Merck, GSK and MITACS and speaker and/or consulting fees from Merck, GSK, AstraZeneca, Roche, Genentech and Respiplus.
: The study protocol and questionnaire were reviewed and approved by the Veritas Independent Review Board prior to study initiation (May 18, 2021; tracking number 2021–2691-6128–3).
: Informed consent was obtained electronically from all respondents prior to study participation.
: Not applicable.